Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
Track This Opportunity
Create an account to track opportunities.
About This Opportunity
This is a grant opportunity from the National Institutes of Health (NIH) for early-stage technology development in basic and clinical cancer research. It's designed for innovators and startups working on novel solutions to advance cancer understanding and treatment. Recipients will receive non-dilutive funding to develop and validate their innovative technologies, specifically excluding clinical trials.
Eligibility Requirements
Application Guide
Proposals will be evaluated based on scientific merit, innovation, relevance to basic and clinical cancer research, feasibility of the technology development plan, and the qualifications of the research team. Adherence to the 'Clinical Trial Not Allowed' stipulation is critical.
Focus on clearly demonstrating the novelty and potential impact of your technology on cancer research. Ensure your proposal meticulously addresses all scientific review criteria and aligns with NIH's strategic goals, emphasizing the early-stage, non-clinical trial nature of the work.
Geographic Coverage
Links & Resources
Source & freshness
Last verified: 6/16/2026
Primary source: Official source page
Refresh cadence: Listings are refreshed weekly.
Reminder: Confirm eligibility and deadlines before applying.